Introduction
Beta-thalassaemia is one of the most common genetic blood disorders
worldwide, caused by a spectrum of mutations that results in a
quantitative reduction of structurally normal β-globin chains. It is
most prevalent in the Mediterranean region, parts of North and
sub-Saharan Africa, the Middle East, Indian subcontinent and Southeast
Asia and it is estimated that 68,000 babies are born each year suffering
from this disease [1], [2].